Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Submitted by
admin
on October 20, 2011 - 9:17am
Source:
Bloomberg
News Tags:
Biogen Idec
FDA
Elan
Tysabri
MS
multiple sclerosis
Headline:
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Do Not Allow Advertisers to Use My Personal information
